Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...

The FDA may be making changes to how it handles COVID-19 booster shots. The agency’s top official says they’re taking a ...

Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.

The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

Comments over the weekend by FDA chief Martin Makary suggest the agency views Novavax’s updated COVID shot as a “new product” ...

Novavax has been available since 2022 through a pandemic-era Emergency Use Authorization. A decision on full approval – which ...

In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...